Results 231 to 240 of about 9,460,673 (364)

Obstetric characteristics and maternal outcomes of early second‐trimester placenta accreta spectrum

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To describe early second‐trimester placenta accreta spectrum (PAS) management and outcomes. Methods This cross‐sectional study queried the US Healthcare Cost and Utilization Project's National Inpatient Sample from 2016 to 2021, finding 905 cases with a diagnosis of PAS between 14 and 22 weeks of gestation and in‐hospital management.
Mihiri S. Karunaratne   +8 more
wiley   +1 more source

Cancer of the vulva: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye   +3 more
wiley   +1 more source

A Retrospective Review: Vaginal versus Abdominal Hysterectomy for Benign Gynecological Diseases in a Tertiary Canter

open access: gold, 2016
Lujain Bukhari   +5 more
openalex   +2 more sources

Protective effect of rooming‐in on postpartum hemorrhage: A propensity score analysis

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study investigates the effect of rooming‐in on postpartum hemorrhage (PPH) and other adverse maternal postpartum outcomes. Methods A retrospective study was performed on all healthy women with singleton term pregnancies at a tertiary medical center between 2013 and 2022.
Natav Hendin   +7 more
wiley   +1 more source

Rhesus testing and anti‐D prophylaxis in RhD‐negative women undergoing first‐trimester abortion—Systematic Review and Opinion

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background The introduction of immunoglobulin G (IgG) anti‐D prophylaxis for Rhesus D (RhD)‐negative women has substantially reduced the incidence of RhD alloimmunization and hemolytic disease of the fetus and newborn in Europe by 85%, transforming fetal health outcomes.
Kristina Gemzell‐Danielsson   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy